Literature DB >> 10527406

Changes of platelet surface antigens in patients suffering from abdominal septic shock.

A Salat1, G Bodingbauer, D Boehm, M Murabito, E Tochkow, T Sautner, M R Mueller, R Fuegger.   

Abstract

Sepsis and related syndromes account for a high morbidity and mortality caused by the development of multiorgan failure. Pathogenesis of sepsis is complex, involving humoral as well as cellular factors. Since the role of platelets is still undefined in this concern, we investigated CD63, CD62P, CD36, and CD31 expression on platelets of patients in septic shock (n = 18) using a flow cytometric assay in whole blood. Samples were drawn within 24 hours of onset. We found thrombocytopenia accompanied by a significantly higher expression of CD63, CD62P, and CD31 and a significant downregulation of CD36 in comparison to healthy volunteers (n = 18). Changes in CD63 and CD62P expression indicates platelet activation. Because CD62P, CD36, and CD31 mediate interaction of platelets with leukocytes, subendothelial matrix and probably endothelial cells as well as platelet adhesion/aggregation, our findings suggest an involvement of platelets in leukocyte/endothelial cell interaction in septic shock. We suspect that thrombocytopenia is not due to bone marrow depression, but rather is due to consumption of highly activated platelets in the microcirculation. We feel that our observations may offer a rationale for potentially beneficial effects of antiplatelet therapy in sepsis; however, further studies have to evaluate its beneficial impact as well as its potential risk for bleeding complications.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10527406     DOI: 10.1016/s0049-3848(99)00046-8

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  5 in total

Review 1.  An Insight into Recent Advances on Platelet Function in Health and Disease.

Authors:  Preeti Kumari Chaudhary; Sanggu Kim; Soochong Kim
Journal:  Int J Mol Sci       Date:  2022-05-27       Impact factor: 6.208

2.  CD63 and C3AR1: The Potential Molecular Targets in the Progression of Septic Shock.

Authors:  Ning Yu; Xuefang Liu; Dandan Shi; Long Bai; Tianfu Niu; Ya Liu
Journal:  Int J Gen Med       Date:  2022-01-19

3.  Exosomal CD63 in critically ill patients with sepsis.

Authors:  Yunjoo Im; Hongseok Yoo; Ryoung-Eun Ko; Jin Young Lee; Junseon Park; Kyeongman Jeon
Journal:  Sci Rep       Date:  2021-10-13       Impact factor: 4.379

Review 4.  Platelets in Sepsis: An Update on Experimental Models and Clinical Data.

Authors:  Alice Assinger; Waltraud C Schrottmaier; Manuel Salzmann; Julie Rayes
Journal:  Front Immunol       Date:  2019-07-17       Impact factor: 7.561

5.  Research Advances in the Subtype of Sepsis-Associated Thrombocytopenia.

Authors:  Xinghui Wu; Yue Li; Huasheng Tong
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.